Patents by Inventor Ursula Boschert

Ursula Boschert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVED TREATMENT METHODS USING DMDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES, AND BIOMARKER FOR PREDICTING AND/OR OPTIMISING SAID TREATMENT METHODS
    Publication number: 20240077481
    Abstract: The invention pertains to improved treatment methods using DMDS, in particular cladribine, for the treatment of autoimmune diseases, in particular multiple sclerosis, and biomarkers, in particular immune cell subtypes, for predicting and/or optimising said treatment methods. The methods described rely on the use of immune cell subtypes, in particular T cells, B cells, NK cells subtypes and their ratios as present in blood samples from the patients for predicting and/or optimising the use of cladribine in the treatment of multiple sclerosis.
    Type: Application
    Filed: March 3, 2022
    Publication date: March 7, 2024
    Inventor: URSULA BOSCHERT SHAFAATIAN
  • Method of treatment comprising administration of a cytokine antagonist molecule
    Patent number: 7803383
    Abstract: This invention relates to novel uses of a protein sequence (INSP052EC), herein identified as an immunoglobulin domain-containing cell surface recognition, in the diagnosis, prevention and treatment of diseases, in particular those related to the excessive expression and/or secretion of cytokines.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: September 28, 2010
    Assignee: Ares Trading S.A.
    Inventors: Richard Joseph Fagan, Andrew Robert Davids, Christopher Benjamin Phelps, Christine Power, Ursula Boschert, Yolande Chvatchko
  • Cytokine antagonist molecules
    Patent number: 7622555
    Abstract: This invention relates to a novel protein (INSP052), herein identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease. The invention also relates to the identification of the extracellular domain of INSP052.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: November 24, 2009
    Assignee: Ares Trading S.A.
    Inventors: Andrew Robert Davids, Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Yolande Chvatchko, Ursula Boschert
  • Metalloprotease proteins
    Patent number: 7557079
    Abstract: This invention relates to proteins termed INSP005a and INSP005b, herein identified as secreted proteins, in particular members of the metalloprotease family and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: July 7, 2009
    Assignee: Ares Trading, S.A.
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Richard James Mitter, Ursula Boschert, Yolande Chvatchko
  • Use of Sdf-1 for the Treatment and/or Prevention of Neurological Diseases
    Publication number: 20080253996
    Abstract: The invention relates to the use of SDF-1, or of an agonist of SDF-1 activity, for the treatment and/or prevention of a neurological disease.
    Type: Application
    Filed: October 30, 2006
    Publication date: October 16, 2008
    Applicant: LABORATORIES SERONO SA
    Inventors: Ursula Boschert, Amanda Proudfoot, Linda Kadi, Pierre Alain Vitte, Jerome Wojcik
  • Lipocalin Protein
    Publication number: 20080254035
    Abstract: The invention is based on the discovery that the human protein referred to herein as INSP181 protein is a lipocalin.
    Type: Application
    Filed: March 8, 2006
    Publication date: October 16, 2008
    Applicant: Ares Trading S.A.
    Inventors: Melanie Yorke-Smith, Christine Power, Ursula Boschert
  • USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES
    Publication number: 20080213234
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Application
    Filed: November 7, 2007
    Publication date: September 4, 2008
    Applicant: LABORATOIRES SERONO SA
    Inventors: Ursula BOSCHERT, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • Cytokine Antagonist Molecules
    Publication number: 20080025951
    Abstract: This invention relates to novel uses of a protein sequence (INSP052EC), herein identified as an immunoglobulin domain-containing cell surface recognition, in the diagnosis, prevention and treatment of diseases, in particular those related to the excessive expression and/or secretion of cytokines.
    Type: Application
    Filed: November 12, 2004
    Publication date: January 31, 2008
    Applicant: ARES TRADING S.A.
    Inventors: Richard Joseph Fagan, Andrew Robert Davids, Christopher Benjamin Phelps, Christine Power, Ursula Boschert, Yolande Chvatchko
  • Use of osteopontin for the treatment and/or prevention of neurologic diseases
    Patent number: 7297099
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: November 20, 2007
    Assignee: Laboratoires Serono SA
    Inventors: Ursula Boschert, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
    Publication number: 20070258901
    Abstract: The invention concerns a capsule containing cells that are transiently transfected with a gene of interest and entrapped within a biocompatible polymer membrane, a method of preparing those capsules, a method for in vivo assessing an activity of the protein secreted by the gene of interest, which comprises administering to a multicellular organism the capsule and detecting an activity, a pharmaceutical composition comprising such a capsule, and the use thereof for the administration of a protein of interest to a subject.
    Type: Application
    Filed: August 2, 2005
    Publication date: November 8, 2007
    Inventors: Ursula Boschert, Holger Heine, Patricia De Lys, Thierry Battle
  • USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES
    Publication number: 20070225214
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 27, 2007
    Applicant: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
    Inventors: Ursula Boschert, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
    Publication number: 20070134260
    Abstract: The invention relates to the use of clusterin, or of an agonist of clusterin activity, for treatment or prevention of peripheral neurological diseases, The invention further relates to the use of a combination of clusterin and heparin, for treatment or prevention of peripheral neurological diseases.
    Type: Application
    Filed: March 26, 2004
    Publication date: June 14, 2007
    Inventors: Georg Feger, Ursula Boschert, Yves Sagot, Ruben Papoian
  • Use of osteopontin for the treatment and/or prevention of neurologic diseases
    Patent number: 7217687
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: May 15, 2007
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Ursula Boschert, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • IL6RIL6 chimera for the treatment of neurodegenerative diseases
    Patent number: 7201896
    Abstract: The invention relates to the use of IL6RIL6 chimera in the treatment and prevention of neurological diseases and disorders.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: April 10, 2007
    Assignees: Yeda Research and Development Company Ltd., Applied Research Systems ARS Holding N.V.
    Inventors: Michel Revel, Judith Chebath, Marina Pizzi, PierFranco Spano, Ursula Boschert
  • Interferon gamma-like protein
    Publication number: 20070044163
    Abstract: This invention relates to a novel protein, termed INSP101, herein identified as a novel splice variant of human pituitary growth hormone and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention, and treatment of disease.
    Type: Application
    Filed: June 21, 2004
    Publication date: February 22, 2007
    Inventors: Richard Fagan, Yolande Chvatchko, Alex Gutteridge, Christine Power, Ursula Boschert, Christopher Phelps
  • Metalloprotease proteins
    Publication number: 20060252117
    Abstract: This invention relates to proteins termed INSPOO5a and INSPOO5b, herein identified as secreted proteins, in particular members of the metalloprotease family and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease.
    Type: Application
    Filed: December 23, 2003
    Publication date: November 9, 2006
    Inventors: Richard Fagan, Christopher Phelps, Christine Power, Richard Mitter, Ursula Boschert, Yolande Chvatchko
  • Use of osteopontin for the treatment and/or prevention of neurologic diseases
    Publication number: 20050176639
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Application
    Filed: November 5, 2004
    Publication date: August 11, 2005
    Applicant: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
    Inventors: Ursula Boschert, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • Use of osteopontin for the treatment and/or prevention of neurologic diseases
    Publication number: 20040235720
    Abstract: The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
    Type: Application
    Filed: April 9, 2004
    Publication date: November 25, 2004
    Inventors: Ursula Boschert, Georg Feger, Raghuram Selvaraju, Lilia Bernasconi, Ruben Papoian
  • Cytokine antagonist molecules
    Publication number: 20040204352
    Abstract: This invention relates to a novel protein (INSP052), herein identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease. The invention also relates to the identification of the extracellular domain of INSP052.
    Type: Application
    Filed: November 12, 2003
    Publication date: October 14, 2004
    Inventors: Andrew Robert Davids, Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Yolande Chvatchko, Ursula Boschert
  • Interferon gamma-like protein
    Publication number: 20040106778
    Abstract: This application discloses and claims a protein, herein identified as an interferon gamma-like secreted protein of the of the four helical bundle cytokine fold, and to the use of this protein and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: June 20, 2003
    Publication date: June 3, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Alex Gutteridge, Christine Power, Ursula Boschert, Yolande Chvatchko